Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

AbbVie Commits to Bringing Novel Drugs to China

publication date: Oct 23, 2015
In September, AbbVie, the US-based big pharma, established a China Development Team to speed development of AbbVie's innovative drugs for the China market. The company considers China an important market, and China's recent drug approval reforms will facilitate the introduction of novel drugs in China, AbbVie says. In 2013, the company set up its China headquarters in Shanghai. AbbVie's upbeat assessment of China is a significant endorsement of the country's porposed changes to its drug regulatory system. More details....

Stock Symbol: (NYSE: ABBV)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital